This RadarView™ provides a holistic view of the leading service providers offering clinical data management and clinical trials services. It begins by summarizing key trends shaping the market’s supply side and continues with a detailed assessment of 19 service providers. Each profile presents an overview of the service provider, its key IP assets, a list of clients and partnerships, and brief client case studies. Each profile concludes with analyst insights on the provider’s practice maturity, domain ecosystem, and investments and innovations.
The clinical data management and clinical trials services market is witnessing a transformational shift driven by several factors, including global economic uncertainties, rising drug development costs, and a focus on patient-centric engagement. Service providers are addressing these challenges by leveraging specialized expertise, expediting time to market, and enhancing data management capabilities. They are also adopting decentralized clinical trial and hybrid clinical trial models to improve patient recruitment and retention while focusing on compliance with changing regulations and safeguarding sensitive patient data.
The Clinical Data Management Business Process Transformation 2024–2025 RadarView™ highlights key supply-side trends in this space and Avasant’s viewpoint on them. It aids companies in identifying top service providers to assist them in clinical data management business process transformation. It also analyzes each service provider’s capabilities in technology and delivery support, enabling organizations to select the right strategic partners for their clinical data management and clinical trials functions.
This RadarView includes a detailed analysis of the following clinical data management business process transformation service providers: Accenture, Advanced Clinical, Axtria, Celerion, Cognizant, Ergomed, EXL, HCLTech, ICON, Indegene, IQVIA, Medpace, Omega Healthcare, PPD, Precision Medicine Group, Premier Research, Syneos Health, TCS, and Veristat.
Our evaluation of service providers is based on primary input from the providers, focused briefings, public disclosures, validation from their clients, and Avasant’s ongoing market interactions. The assessment is across the three dimensions of practice maturity, domain ecosystem, and investments and innovation, leading to our recognition of service providers that have brought the most value to the market over the past 12 months.
About the report (Page 3)
Executive summary (Pages 4–9)
Supply-side trends (Pages 10–15)
Service provider profiles (Pages 16–54)
Appendix (Pages 55–58)
Key contacts (Page 59)
Read the Research Byte based on this report. Please refer to Avasant’s Clinical Data Management Business Process Transformation 2024–2025 Market Insights™ for demand-side trends.
Avasant’s research and other publications are based on information from the best available sources and Avasant’s independent assessment and analysis at the time of publication. Avasant takes no responsibility and assumes no liability for any error/omission or the accuracy of information contained in its research publications. Avasant does not endorse any provider, product or service described in its RadarView™ publications or any other research publications that it makes available to its users, and does not advise users to select only those providers recognized in these publications. Avasant disclaims all warranties, expressed or implied, including any warranties of merchantability or fitness for a particular purpose. None of the graphics, descriptions, research, excerpts, samples or any other content provided in the report(s) or any of its research publications may be reprinted, reproduced, redistributed or used for any external commercial purpose without prior permission from Avasant, LLC. All rights are reserved by Avasant, LLC.
Login to get free content each month and build your personal library at Avasant.com
